MyMD Pharmaceuticals Ownership 2024 | Who Owns MyMD Pharmaceuticals Now?

OverviewFinancials Chart

Institutional Ownership

0.01%

Insider Ownership

6.61%

Retail Ownership

93.37%

Institutional Holders

2.00

MyMD Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VANGUARD GROUP INC	32.80%	0.00%	1,458,295	-	-	2,508,267,000	Mar 31, 2023
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.	26.40%	0.00%	1,173,610	417,125	55.14%	2,018,609,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	6.21%	0.00%	276,298	-	-	475,232,000	Mar 31, 2023
BLACKROCK INC.	4.60%	-	204,657	7,336	3.72%	352,010,000	Mar 31, 2023
STATE STREET CORP	2.70%	-	120,252	18,500	18.18%	206,833,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	2.22%	-	98,592	27,026	37.76%	169,578,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	1.69%	-	75,216	75,004	35379.25%	129,372,000	Mar 31, 2023
CITADEL ADVISORS LLC	1.67%	-	74,200	-31,000	-29.47%	127,624,000	Mar 31, 2023
M HOLDINGS SECURITIES, INC.	1.59%	0.01%	70,909	-	-	122,000	Mar 31, 2023
CAMBRIA INVESTMENT MANAGEMENT, L.P.	1.39%	0.01%	61,956	-6,884	-10.00%	106,564,000	Mar 31, 2023
NORTHERN TRUST CORP	1.35%	-	60,090	4,734	8.55%	103,355,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.92%	-	40,900	40,900	100.00%	70,348,000	Mar 31, 2023
FIDELIS CAPITAL PARTNERS, LLC	0.87%	0.03%	38,590	-	-	64,831,000	Mar 31, 2023
MORGAN STANLEY	0.85%	-	37,967	-147,728	-79.55%	65,303,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.78%	-	34,800	1,600	4.82%	59,856,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.74%	0.00%	33,100	32,300	4037.50%	56,932,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.71%	0.00%	31,707	24,947	369.04%	54,536,000	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.67%	-	30,001	-7,763	-20.56%	51,602,000	Mar 31, 2023
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	0.59%	0.00%	26,023	1,223	4.93%	44,760,000	Mar 31, 2023
PARALLEL ADVISORS, LLC	0.57%	0.00%	25,125	25,125	100.00%	43,215,000	Mar 31, 2023

MyMD Pharmaceuticals's largest institutional shareholder is VANGUARD GROUP INC, holding 32.80% of the company's total share outstanding, currently valued at $2.51B. The top 10 institutional shareholders own together 81.29% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
FIDELIS CAPITAL PARTNERS, LLC	0.87%	0.03%	38,590	-	-	64,831,000	Mar 31, 2023
TAYLOR & MORGAN WEALTH MANAGEMENT, LLC	0.36%	0.02%	16,086	-1,000	-5.85%	27,668,000	Mar 31, 2023
CORUNDUM GROUP, INC.	0.44%	0.02%	19,600	-	-	33,712,000	Mar 31, 2023
PRAETORIAN WEALTH MANAGEMENT, INC.	0.56%	0.01%	25,000	-	-	43,000,000	Mar 31, 2023
M HOLDINGS SECURITIES, INC.	1.59%	0.01%	70,909	-	-	122,000	Mar 31, 2023
CAMBRIA INVESTMENT MANAGEMENT, L.P.	1.39%	0.01%	61,956	-6,884	-10.00%	106,564,000	Mar 31, 2023
BRIDGECREEK INVESTMENT MANAGEMENT, LLC	0.34%	0.01%	15,000	-	-	25,800,000	Mar 31, 2023
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.	26.40%	0.00%	1,173,610	417,125	55.14%	2,018,609,000	Mar 31, 2023
NWAM LLC	0.56%	0.00%	25,000	25,000	100.00%	43,000,000	Mar 31, 2023
SEACREST WEALTH MANAGEMENT, LLC	0.29%	0.00%	12,850	12,850	100.00%	22,102,000	Mar 31, 2023
PARALLEL ADVISORS, LLC	0.57%	0.00%	25,125	25,125	100.00%	43,215,000	Mar 31, 2023
KESTRA PRIVATE WEALTH SERVICES, LLC	0.27%	0.00%	12,100	12,100	100.00%	20,812,000	Mar 31, 2023
ST. JOHNS INVESTMENT MANAGEMENT COMPANY, LLC	0.01%	0.00%	494	-	-	850,000	Mar 31, 2023
SIMPLICITY SOLUTIONS, LLC	0.22%	0.00%	10,000	10,000	100.00%	17,200,000	Mar 31, 2023
SANDY SPRING BANK	0.08%	0.00%	3,460	-	-	5,952,000	Mar 31, 2023
LEVEL FINANCIAL ADVISORS, INC.	0.00%	0.00%	200	200	100.00%	344,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.74%	0.00%	33,100	32,300	4037.50%	56,932,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.71%	0.00%	31,707	24,947	369.04%	54,536,000	Mar 31, 2023
ANCORA ADVISORS, LLC	0.06%	0.00%	2,700	-	-	4,644,000	Mar 31, 2023
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.	0.59%	0.00%	26,023	1,223	4.93%	44,760,000	Mar 31, 2023

The largest MyMD Pharmaceuticals shareholder by % of total assets is FIDELIS CAPITAL PARTNERS, LLC. The company owns 38.59K shares of MyMD Pharmaceuticals (MYMD), representing 0.03% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.	26.40%	0.00%	1,173,610	417,125	55.14%	2,018,609,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	1.69%	-	75,216	75,004	35379.25%	129,372,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.92%	-	40,900	40,900	100.00%	70,348,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.74%	0.00%	33,100	32,300	4037.50%	56,932,000	Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	2.22%	-	98,592	27,026	37.76%	169,578,000	Mar 31, 2023
PARALLEL ADVISORS, LLC	0.57%	0.00%	25,125	25,125	100.00%	43,215,000	Mar 31, 2023
NWAM LLC	0.56%	0.00%	25,000	25,000	100.00%	43,000,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.71%	0.00%	31,707	24,947	369.04%	54,536,000	Mar 31, 2023
STATE STREET CORP	2.70%	-	120,252	18,500	18.18%	206,833,000	Mar 31, 2023
COMMONWEALTH EQUITY SERVICES, LLC	0.38%	0.00%	17,044	17,044	100.00%	29,000	Mar 31, 2023
CI PRIVATE WEALTH, LLC	0.34%	0.00%	15,000	15,000	100.00%	25,800,000	Mar 31, 2023
SEACREST WEALTH MANAGEMENT, LLC	0.29%	0.00%	12,850	12,850	100.00%	22,102,000	Mar 31, 2023
KESTRA PRIVATE WEALTH SERVICES, LLC	0.27%	0.00%	12,100	12,100	100.00%	20,812,000	Mar 31, 2023
GROUP ONE TRADING, L.P.	0.28%	0.00%	12,500	11,400	1036.36%	21,500,000	Mar 31, 2023
SIMPLICITY SOLUTIONS, LLC	0.22%	0.00%	10,000	10,000	100.00%	17,200,000	Mar 31, 2023
SIMPLEX TRADING, LLC	0.36%	-	16,062	9,864	159.15%	27,000	Mar 31, 2023
BLACKROCK INC.	4.60%	-	204,657	7,336	3.72%	352,010,000	Mar 31, 2023
NORTHERN TRUST CORP	1.35%	-	60,090	4,734	8.55%	103,355,000	Mar 31, 2023
SIMPLEX TRADING, LLC	0.14%	-	6,000	4,000	200.00%	10,000	Mar 31, 2023
SIMPLEX TRADING, LLC	0.17%	-	7,400	2,000	37.04%	12,000	Mar 31, 2023

As of Mar 31 2023, MyMD Pharmaceuticals's largest institutional buyer is MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.. The company purchased 417.13K stocks of MYMD, valued at $2.02B.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SHAY CAPITAL LLC	-	-	-	-207,235	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	0.85%	-	37,967	-147,728	-79.55%	65,303,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-68,312	-100.00%	-	Mar 31, 2023
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC	-	-	-	-67,000	-100.00%	-	Mar 31, 2023
CITADEL ADVISORS LLC	1.67%	-	74,200	-31,000	-29.47%	127,624,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-30,084	-100.00%	-	Mar 31, 2023
WOLVERINE TRADING, LLC	-	-	-	-19,600	-100.00%	-	Mar 31, 2023
BANK OF AMERICA CORP /DE/	0.67%	-	30,001	-7,763	-20.56%	51,602,000	Mar 31, 2023
UBS GROUP AG	-	-	-	-7,312	-100.00%	-	Mar 31, 2023
CAMBRIA INVESTMENT MANAGEMENT, L.P.	1.39%	0.01%	61,956	-6,884	-10.00%	106,564,000	Mar 31, 2023
CITADEL ADVISORS LLC	0.11%	-	4,864	-4,808	-49.71%	8,366,000	Mar 31, 2023
TAYLOR & MORGAN WEALTH MANAGEMENT, LLC	0.36%	0.02%	16,086	-1,000	-5.85%	27,668,000	Mar 31, 2023
GENEOS WEALTH MANAGEMENT INC.	0.01%	0.00%	500	-225	-31.03%	860,000	Mar 31, 2023
IFP ADVISORS, INC	-	-	-	-2	-100.00%	-	Mar 31, 2023
FIDELIS CAPITAL PARTNERS, LLC	0.87%	0.03%	38,590	-	-	64,831,000	Mar 31, 2023
CORUNDUM GROUP, INC.	0.44%	0.02%	19,600	-	-	33,712,000	Mar 31, 2023
PRAETORIAN WEALTH MANAGEMENT, INC.	0.56%	0.01%	25,000	-	-	43,000,000	Mar 31, 2023
M HOLDINGS SECURITIES, INC.	1.59%	0.01%	70,909	-	-	122,000	Mar 31, 2023
BRIDGECREEK INVESTMENT MANAGEMENT, LLC	0.34%	0.01%	15,000	-	-	25,800,000	Mar 31, 2023
ST. JOHNS INVESTMENT MANAGEMENT COMPANY, LLC	0.01%	0.00%	494	-	-	850,000	Mar 31, 2023

As of Mar 31 2023, MyMD Pharmaceuticals's biggest institutional seller is SHAY CAPITAL LLC. The company sold -0.21M shares of MYMD, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.92%	-	40,900	40,900	100.00%	70,348,000	Mar 31, 2023
PARALLEL ADVISORS, LLC	0.57%	0.00%	25,125	25,125	100.00%	43,215,000	Mar 31, 2023
NWAM LLC	0.56%	0.00%	25,000	25,000	100.00%	43,000,000	Mar 31, 2023
COMMONWEALTH EQUITY SERVICES, LLC	0.38%	0.00%	17,044	17,044	100.00%	29,000	Mar 31, 2023
CI PRIVATE WEALTH, LLC	0.34%	0.00%	15,000	15,000	100.00%	25,800,000	Mar 31, 2023
SEACREST WEALTH MANAGEMENT, LLC	0.29%	0.00%	12,850	12,850	100.00%	22,102,000	Mar 31, 2023
KESTRA PRIVATE WEALTH SERVICES, LLC	0.27%	0.00%	12,100	12,100	100.00%	20,812,000	Mar 31, 2023
SIMPLICITY SOLUTIONS, LLC	0.22%	0.00%	10,000	10,000	100.00%	17,200,000	Mar 31, 2023
FMR LLC	0.02%	-	1,000	1,000	100.00%	1,720,000	Mar 31, 2023
ROYAL BANK OF CANADA	0.02%	-	913	913	100.00%	2,000,000	Mar 31, 2023
JPMORGAN CHASE & CO	0.01%	-	347	347	100.00%	1,000,000	Mar 31, 2023
STRATEGIC INVESTMENT SOLUTIONS, INC. /IL	0.00%	0.00%	200	200	100.00%	344,000	Mar 31, 2023
LEVEL FINANCIAL ADVISORS, INC.	0.00%	0.00%	200	200	100.00%	344,000	Mar 31, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	0.00%	-	74	74	100.00%	127,000	Mar 31, 2023
NEWEDGE ADVISORS, LLC	-	-	1	1	100.00%	2,000	Mar 31, 2023

MyMD Pharmaceuticals's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 40.90K shares, valued at $70.35M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SHAY CAPITAL LLC	-	-	-	-207,235	-100.00%	-	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	-	-68,312	-100.00%	-	Mar 31, 2023
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC	-	-	-	-67,000	-100.00%	-	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-30,084	-100.00%	-	Mar 31, 2023
WOLVERINE TRADING, LLC	-	-	-	-19,600	-100.00%	-	Mar 31, 2023
UBS GROUP AG	-	-	-	-7,312	-100.00%	-	Mar 31, 2023
IFP ADVISORS, INC	-	-	-	-2	-100.00%	-	Mar 31, 2023

MyMD Pharmaceuticals's largest sold out institutional shareholder by shares sold is SHAY CAPITAL LLC, sold -0.21M shares, valued at -, as of undefined.

MyMD Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD VALLEY FORGE FUNDS	0.05%	25,990	-	-	Dec 31, 2023
Cambria ETF Trust	0.02%	161,766	-9,804	-5.71%	Jan 31, 2024
VANGUARD INDEX FUNDS	0.00%	1,807,659	410,666	29.40%	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	270,655	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	26,030	-	-	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.00%	126,191	-	-	Feb 29, 2024
SCHWAB CAPITAL TRUST	0.00%	13,965	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	142,387	-	-	Dec 31, 2023
EQ ADVISORS TRUST	0.00%	7,406	-	-	Dec 31, 2023
iSHARES TRUST	0.00%	84,695	-	-	Feb 29, 2024

MyMD Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 25.99K shares, compromising 0.05% of its total assets.

MyMD Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 22	2	-
31 Mar, 21	18	20.00%
31 Dec, 20	15	7.14%
30 Sep, 20	14	75.00%
30 Jun, 20	8	-20.00%
31 Mar, 20	10	42.86%
31 Dec, 19	7	600.00%
30 Sep, 19	1	-

As of 31 Mar 22, 2 institutions are holding MyMD Pharmaceuticals's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 22	5,600	-
31 Mar, 21	1,166,571	-8.80%
31 Dec, 20	1,279,111	187.18%
30 Sep, 20	445,401	537.93%
30 Jun, 20	69,820	-80.78%
31 Mar, 20	363,293	-15.75%
31 Dec, 19	431,217	11.28%
30 Sep, 19	387,520	-

MyMD Pharmaceuticals (MYMD) has 5.60K shares outstanding as of 31 Mar 22, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 22	0.01%	-
31 Mar, 21	3.14%	26.48%
31 Dec, 20	3.44%	239.44%
30 Sep, 20	1.20%	3393.24%
30 Jun, 20	0.19%	19.65%
31 Mar, 20	0.98%	72.55%
31 Dec, 19	1.16%	106.64%
30 Sep, 19	1.04%	-

As of 31 Mar 22, MyMD Pharmaceuticals is held by 0.01% institutional shareholders, representing a 0.00% growth compared to 31 Mar 21.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 22	2	-
31 Mar, 21	9	12.50%
31 Dec, 20	8	-27.27%
30 Sep, 20	11	175.00%
30 Jun, 20	4	-33.33%
31 Mar, 20	6	-
31 Dec, 19	6	500.00%
30 Sep, 19	1	-

2 institutional shareholders have increased their position in MYMD stock as of 31 Mar 22 compared to 9 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 22	-	-
31 Mar, 21	2	-
31 Dec, 20	2	100.00%
30 Sep, 20	1	-
30 Jun, 20	-	-100.00%
31 Mar, 20	2	100.00%
31 Dec, 19	1	-
30 Sep, 19	-	-

- institutional shareholders have reduced their position in MYMD stock as of 31 Mar 22 compared to 2 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 22	2	-	5,600	-	0.01%	-	2	-	-	-
31 Mar, 21	18	20.00%	1,166,571	-8.80%	3.14%	26.48%	9	12.50%	2	-
31 Dec, 20	15	7.14%	1,279,111	187.18%	3.44%	239.44%	8	-27.27%	2	100.00%
30 Sep, 20	14	75.00%	445,401	537.93%	1.20%	3393.24%	11	175.00%	1	-
30 Jun, 20	8	-20.00%	69,820	-80.78%	0.19%	19.65%	4	-33.33%	-	-100.00%
31 Mar, 20	10	42.86%	363,293	-15.75%	0.98%	72.55%	6	-	2	100.00%
31 Dec, 19	7	600.00%	431,217	11.28%	1.16%	106.64%	6	500.00%	1	-
30 Sep, 19	1	-	387,520	-	1.04%	-	1	-	-	-

MyMD Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 24, 2023	Rivard Paul	officer	Chief Legal Officer	P-Purchase	Buy	150,000	$1.11	$166.50K	400,000
Aug 18, 2023	Rivard Paul	officer	Chief Legal Officer	P-Purchase	Buy	25,000	$1.12	$28.08K	250,000
Dec 08, 2022	Rivard Paul	officer	EVP of Operations, GC	P-Purchase	Buy	10,000	$1.53	$15.30K	225,000
Nov 29, 2021	Silverman Joshua	director	-	P-Purchase	Buy	5,000	$7.55	$37.77K	88,775
Nov 29, 2021	Silverman Joshua	director	-	P-Purchase	Buy	3,266	$7.09	$23.17K	83,775
Nov 29, 2021	Silverman Joshua	director	-	P-Purchase	Buy	6,734	$6.30	$42.42K	80,509
Nov 24, 2021	Rivard Paul	officer	EVP of Operations, GC	P-Purchase	Buy	15,000	$6.03	$90.45K	215,000

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Aug 24, 2023	Rivard Paul	officer	Chief Legal Officer	P-Purchase	Buy	150,000	$1.11	$166.50K	400,000
Aug 18, 2023	Rivard Paul	officer	Chief Legal Officer	P-Purchase	Buy	25,000	$1.12	$28.08K	250,000
Dec 08, 2022	Rivard Paul	officer	EVP of Operations, GC	P-Purchase	Buy	10,000	$1.53	$15.30K	225,000
Nov 29, 2021	Silverman Joshua	director	-	P-Purchase	Buy	5,000	$7.55	$37.77K	88,775
Nov 29, 2021	Silverman Joshua	director	-	P-Purchase	Buy	3,266	$7.09	$23.17K	83,775
Nov 29, 2021	Silverman Joshua	director	-	P-Purchase	Buy	6,734	$6.30	$42.42K	80,509
Nov 24, 2021	Rivard Paul	officer	EVP of Operations, GC	P-Purchase	Buy	15,000	$6.03	$90.45K	215,000

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 16, 2024	Glass Mitchell	director			Buy	-	-	-	-
Aug 24, 2023	Rivard Paul	officer	Chief Legal Officer	P-Purchase	Buy	150,000	$1.11	$166.50K	400,000
Aug 18, 2023	Rivard Paul	officer	Chief Legal Officer	P-Purchase	Buy	25,000	$1.12	$28.08K	250,000
Jun 09, 2023	Chapman Christopher C JR	director, officer	President, Chief Med. Officer	A-Award	Buy	300,000	$1.66	$498.00K	300,000
Jun 09, 2023	Kaplin Adam	officer	Chief Scientific Officer	A-Award	Buy	150,000	$1.66	$249.00K	150,000
Jun 09, 2023	Uzonwanne Jude	director	-	A-Award	Buy	150,000	$1.66	$249.00K	150,000
Jun 09, 2023	Schreiber Christopher C	director	-	A-Award	Buy	150,000	$1.66	$249.00K	150,000
Jun 09, 2023	EAGLE CRAIG	director	-	A-Award	Buy	475,000	$1.66	$788.50K	475,000
Jun 09, 2023	Silverman Joshua	director	-	A-Award	Buy	200,000	$1.66	$332.00K	200,000
Jun 09, 2023	White Billy Joe	director	-	A-Award	Buy	150,000	$1.66	$249.00K	150,000
Jun 09, 2023	Rivard Paul	officer	Chief Legal Officer	A-Award	Buy	150,000	$1.66	$249.00K	150,000
Apr 05, 2023	Chapman Christopher C JR	director, officer	President, Chief Med. Officer	A-Award	Buy	750,000	$1.55	$1.16M	750,000
Dec 08, 2022	Rivard Paul	officer	EVP of Operations, GC	P-Purchase	Buy	10,000	$1.53	$15.30K	225,000
Nov 29, 2021	Silverman Joshua	director	-	P-Purchase	Buy	5,000	$7.55	$37.77K	88,775
Nov 29, 2021	Silverman Joshua	director	-	P-Purchase	Buy	3,266	$7.09	$23.17K	83,775
Nov 29, 2021	Silverman Joshua	director	-	P-Purchase	Buy	6,734	$6.30	$42.42K	80,509
Nov 24, 2021	Rivard Paul	officer	EVP of Operations, GC	P-Purchase	Buy	15,000	$6.03	$90.45K	215,000
Oct 15, 2021	Kaplin Adam	officer	Chief Scientific Officer	A-Award	Buy	600,000	-	-	600,000
Oct 15, 2021	Schreiber Christopher C	director	-	A-Award	Buy	150,000	-	-	150,000
Oct 15, 2021	White Billy Joe	director	-	A-Award	Buy	150,000	-	-	150,000

The last insider buy of MYMD was made by Rivard Paul on Aug 24 2023, buying 150,000 shares at $1.11 per share (worth $166.50K).

MyMD Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2023	2	-	-
Q2 2023	9	-	-
Q4 2022	1	-	-
Q4 2021	12	-	-
Q2 2021	12	9	133.33%
Q1 2021	-	-	-
Q3 2020	4	-	-
Q1 2020	6	1	600.00%
Q4 2019	13	-	-
Q3 2019	2	-	-
Q2 2019	1	-	-
Q1 2019	4	-	-
Q4 2018	1	-	-
Q3 2018	-	-	-
Q2 2018	-	-	-
Q4 2017	3	-	-
Q3 2017	-	-	-
Q4 2016	-	-	-
Q2 2016	7	-	-
Q1 2016	1	-	-

2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by MyMD Pharmaceuticals's insiders, as of Q3 2023.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2023	2	-	-
Q2 2023	-	-	-
Q4 2022	1	-	-
Q4 2021	4	-	-
Q2 2021	-	-	-
Q1 2021	-	-	-
Q3 2020	-	-	-
Q1 2020	-	1	-
Q4 2019	12	-	-
Q3 2019	-	-	-
Q2 2019	-	-	-
Q1 2019	-	-	-
Q4 2018	-	-	-
Q3 2018	-	-	-
Q2 2018	-	-	-
Q4 2017	-	-	-
Q3 2017	-	-	-
Q4 2016	-	-	-
Q2 2016	5	-	-
Q1 2016	1	-	-

As of Q3 2023, Insider owners conducted 2 open market buy trades and 0 open market sell trades of MyMD Pharmaceuticals's stocks.

MyMD Pharmaceuticals Peer Ownership

Ticker	Company
SRZN	Surrozen, Inc.
DSGN	Design Therapeutics, Inc.
AVIR	Atea Pharmaceuticals, Inc.
NVCT	Nuvectis Pharma, Inc.
KROS	Keros Therapeutics, Inc.
ORIC	ORIC Pharmaceuticals, Inc.
PASG	Passage Bio, Inc.
LGND	Ligand Pharmaceuticals Incorporated
GOSS	Gossamer Bio, Inc.
XBIO	Xenetic Biosciences, Inc.
YS	LakeShore Biopharma Co., Ltd
REVB	Revelation Biosciences, Inc.
LRMR	Larimar Therapeutics, Inc.
GOVX	GeoVax Labs, Inc.
RXRX	Recursion Pharmaceuticals, Inc.
LYEL	Lyell Immunopharma, Inc.
BOLT	Bolt Biotherapeutics, Inc.
KZR	Kezar Life Sciences, Inc.
UBX	Unity Biotechnology, Inc.
EXAI	Exscientia plc
LYRA	Lyra Therapeutics, Inc.
KRON	Kronos Bio, Inc.
REPL	Replimune Group, Inc.

MYMD Ownership FAQ

Who Owns MyMD Pharmaceuticals?

MyMD Pharmaceuticals is owned by institutional shareholders (0.01%), insiders (6.61%), and public (93.37%). The largest institutional shareholder of MyMD Pharmaceuticals is VANGUARD GROUP INC (32.80% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.05% of total shares).

Who are the major institutional shareholders of MyMD Pharmaceuticals?

MyMD Pharmaceuticals's major institutional shareholders are VANGUARD GROUP INC, MIRAE ASSET GLOBAL INVESTMENTS CO., LTD., GEODE CAPITAL MANAGEMENT, LLC, BLACKROCK INC., and STATE STREET CORP. The top five shareholders own together 72.72% of the company's share outstanding.

How many MyMD Pharmaceuticals shareholders are there?

As of Mar 2022, there are 2 institutional shareholders of MyMD Pharmaceuticals.

What percentage of MyMD Pharmaceuticals is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC owns 1.46M shares of MyMD Pharmaceuticals, representing 32.80% of the company's total shares outstanding, valued at $2.51B (as of Mar 2023).

What percentage of MyMD Pharmaceuticals is owned by MIRAE ASSET GLOBAL INVESTMENTS CO., LTD?

As of Mar 2023, MIRAE ASSET GLOBAL INVESTMENTS CO., LTD holds 1.17M shares of MyMD Pharmaceuticals (MYMD), compromising 26.40% of the company, valued at $2.02B.

What percentage of MyMD Pharmaceuticals is owned by GEODE CAPITAL MANAGEMENT, LLC?

GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of MyMD Pharmaceuticals. The company owns 276.3K of the company's shares outstanding (worth $475.23M).